Literature DB >> 17659806

Drug delivery to peroxisomes: employing unique trafficking mechanisms to target protein therapeutics.

Stanley R Terlecky1, Jay I Koepke.   

Abstract

Peroxisomes are multifunctional organelles of all human cells, responsible for a variety of essential biochemical and metabolic processes including alpha- and beta-oxidation of specific fatty acids, plasmalogen biosynthesis and glyoxylate detoxification. Inborn errors of biogenesis or in the ability to synthesize or properly traffic specific enzymes to peroxisomes result in devastating human disease. The organelle has also emerged as a contributor to cellular oxidative stress through its ability to generate hydrogen peroxide. Unlike most other organelles, the peroxisome's import apparatus will accommodate fully folded, oligomeric and co-factor-bound substrates. The strategies outlined here are designed to take advantage of this unique mechanism to target protein therapeutics. Emphasis is also placed on how to deliver these bioactive molecules into cells to engage the peroxisomal protein import machine. The critical antioxidant enzyme catalase has been successfully delivered and targeted by many of the approaches detailed herein; these examples will be discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17659806     DOI: 10.1016/j.addr.2007.06.005

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  13 in total

1.  A targeted enzyme approach to sensitization of tyrosine kinase inhibitor-resistant breast cancer cells.

Authors:  Courtney R Giordano; Kelly L Mueller; Laura J Terlecky; Kendra A Krentz; Aliccia Bollig-Fischer; Stanley R Terlecky; Julie L Boerner
Journal:  Exp Cell Res       Date:  2012-06-08       Impact factor: 3.905

Review 2.  Strategies in the design of nanoparticles for therapeutic applications.

Authors:  Robby A Petros; Joseph M DeSimone
Journal:  Nat Rev Drug Discov       Date:  2010-07-09       Impact factor: 84.694

Review 3.  Direct Drug Targeting into Intracellular Compartments: Issues, Limitations, and Future Outlook.

Authors:  Gamaleldin I Harisa; Tarek M Faris
Journal:  J Membr Biol       Date:  2019-08-02       Impact factor: 1.843

Review 4.  Molecular therapy of primary hyperoxaluria.

Authors:  Cristina Martin-Higueras; Armando Torres; Eduardo Salido
Journal:  J Inherit Metab Dis       Date:  2017-04-19       Impact factor: 4.982

Review 5.  Controlling subcellular delivery to optimize therapeutic effect.

Authors:  Mohanad Mossalam; Andrew S Dixon; Carol S Lim
Journal:  Ther Deliv       Date:  2010-07

Review 6.  Peroxisomes, cell senescence, and rates of aging.

Authors:  Courtney R Giordano; Stanley R Terlecky
Journal:  Biochim Biophys Acta       Date:  2012-03-29

7.  Toward intracellular targeted delivery of cancer therapeutics: progress and clinical outlook for brain tumor therapy.

Authors:  Hetal Pandya; Waldemar Debinski
Journal:  BioDrugs       Date:  2012-08-01       Impact factor: 5.807

8.  A role for hydrogen peroxide in the pro-apoptotic effects of photodynamic therapy.

Authors:  Michael Price; Stanley R Terlecky; David Kessel
Journal:  Photochem Photobiol       Date:  2009 Nov-Dec       Impact factor: 3.421

9.  Direct delivery of functional proteins and enzymes to the cytosol using nanoparticle-stabilized nanocapsules.

Authors:  Chang Soo Kim; David J Solfiell; Subinoy Rana; Rui Tang; Rubul Mout; Elih M Velázquez-Delgado; Apiwat Chompoosor; Youngdo Jeong; Bo Yan; Zheng-Jiang Zhu; Chaekyu Kim; Jeanne A Hardy; Vincent M Rotello
Journal:  ACS Nano       Date:  2013-07-08       Impact factor: 15.881

10.  Reactive oxygen species in tumor necrosis factor-alpha-activated primary human keratinocytes: implications for psoriasis and inflammatory skin disease.

Authors:  Chen N Young; Jay I Koepke; Laura J Terlecky; Michael S Borkin; Savoy L Boyd; Stanley R Terlecky
Journal:  J Invest Dermatol       Date:  2008-05-08       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.